Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
17.03%
operating margin TTM
19.86%
revenue TTM
2.88 Billion
revenue per share TTM
39.81$
valuation ratios | |
|---|---|
| pe ratio | 30.11 |
| peg ratio | -29.29 |
| price to book ratio | 5.53 |
| price to sales ratio | 5.08 |
| enterprise value multiple | 20.10 |
| price fair value | 5.53 |
profitability ratios | |
|---|---|
| gross profit margin | 34.56% |
| operating profit margin | 19.86% |
| pretax profit margin | 20.24% |
| net profit margin | 17.03% |
| return on assets | 13.52% |
| return on equity | 18.43% |
| return on capital employed | 18.57% |
liquidity ratio | |
|---|---|
| current ratio | 2.79 |
| quick ratio | 2.11 |
| cash ratio | 0.88 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 72.68 |
| operating cycle | 142.38 |
| days of payables outstanding | 46.13 |
| cash conversion cycle | 96.25 |
| receivables turnover | 5.24 |
| payables turnover | 7.91 |
| inventory turnover | 5.02 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.08 |
| debt equity ratio | 0.11 |
| long term debt to capitalization | 0.07 |
| total debt to capitalization | 0.10 |
| interest coverage | 191.50 |
| cash flow to debt ratio | 2.16 |
cash flow ratios | |
|---|---|
| free cash flow per share | 3.79 |
| cash per share | 6.64 |
| operating cash flow per share | 8.95 |
| free cash flow operating cash flow ratio | 0.42 |
| cash flow coverage ratios | 2.16 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 1.73 |
Frequently Asked Questions
When was the last time West Pharmaceutical Services, Inc. (NYSE:WST) reported earnings?
West Pharmaceutical Services, Inc. (WST) published its most recent earnings results on 24-10-2024.
What is West Pharmaceutical Services, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. West Pharmaceutical Services, Inc. (NYSE:WST)'s trailing twelve months ROE is 18.43%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. West Pharmaceutical Services, Inc. (WST) currently has a ROA of 13.52%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did WST's net profit margin stand at?
WST reported a profit margin of 17.03% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is WST's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.79 in the most recent quarter. The quick ratio stood at 2.11, with a Debt/Eq ratio of 0.11.